Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Adrenal Cortex Neoplasms × Axitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pheochromocytoma 1 Paraganglioma 1 Neoplasms 1 Carcinoma, Renal Cell 1 Adrenal Cortex Neoplasms 1

Interventions

tariquidar 1 Floxuridine 1 Dexamethasone 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01255137 2013-06-27

Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Completed

13 enrolled 9 charts

Adrenal Cortex Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡